Literature DB >> 21393581

In vivo fluorescence imaging of large-vessel thrombosis in mice.

Brian C Cooley1.   

Abstract

OBJECTIVE: Experimental studies of large-vessel thrombosis have been adapted for applications in mice, but they proffer limited quantifiable information in outcome measures. This study presents a novel approach for evaluating large-vessel thrombogenesis with temporally/spatially quantifiable measures and normalization methods for interanimal comparisons. METHODS AND
RESULTS: Shuttered, beam-expanded lasers provided uniform narrow-wavelength illumination of a ×100 microsurgical field with a large depth of focus. Thrombosis was generated in murine carotid arteries and femoral veins by brief vascular surface electrolytic injury. Thrombus-targeting fluorophores were injected systemically and subsequently localized at the site of thrombus induction. A low-light digital video camera with filter wheel provided target-specific image acquisition over a 60-minute interval. Platelets accumulated with a subsequent fibrin border emerging to stabilize the clot in both arteries and veins. Coagulation enzyme complexes colocalized with fibrin deposition. Large arteries underwent cyclic massive thromboembolization, whereas veins showed gradual shedding of microemboli and clot contraction. Systemic administration of fibrin- and platelet-inhibiting compounds reduced their respective targets but also often inhibited their clotting counterparts (platelets and fibrin, respectively) in both arteries and veins.
CONCLUSION: Intermediate-level magnified image capture represents a novel approach for analysis of fluorescence-based in vivo imaging, with quantitative application to the study of large-vessel thrombosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393581      PMCID: PMC3098306          DOI: 10.1161/ATVBAHA.111.225334

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  18 in total

1.  Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivo.

Authors:  M S Runge; C Bode; G R Matsueda; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen.

Authors:  K Y Hui; E Haber; G R Matsueda
Journal:  Science       Date:  1983-12-09       Impact factor: 47.728

3.  The pathogenesis of a coronary thrombus.

Authors:  M Friedman; G J Van den Bovenkamp
Journal:  Am J Pathol       Date:  1966-01       Impact factor: 4.307

4.  Spontaneous thrombosis in mice carrying the factor V Leiden mutation.

Authors:  J Cui; D T Eitzman; R J Westrick; P D Christie; Z J Xu; A Y Yang; A A Purkayastha; T L Yang; A L Metz; K P Gallagher; J A Tyson; R D Rosenberg; D Ginsburg
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

5.  Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi.

Authors:  E D Rosen; S Raymond; A Zollman; F Noria; M Sandoval-Cooper; A Shulman; J L Merz; F J Castellino
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

6.  Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse.

Authors:  Shahrokh Falati; Peter Gross; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

7.  The structure and growth of valve-pocket thrombi in femoral veins.

Authors:  S Sevitt
Journal:  J Clin Pathol       Date:  1974-07       Impact factor: 3.411

8.  A new primate model for the study of intravenous thrombotic potential and its modification.

Authors:  N A Shoenfeld; A Yeager; R Connolly; K Ramberg; L Forgione; A Giorgio; C R Valeri; A D Callow
Journal:  J Vasc Surg       Date:  1988-07       Impact factor: 4.268

9.  Estimation of thrombus formation by labeling of platelets, red cells and fibrinogen in experimental thrombosis.

Authors:  R Zimmermann; C Zeltsch; D Lange
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

10.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Authors:  T Koster; F R Rosendaal; H de Ronde; E Briët; J P Vandenbroucke; R M Bertina
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

View more
  32 in total

1.  Fibrinogen counteracts the antiadhesive effect of fibrin-bound plasminogen by preventing its activation by adherent U937 monocytic cells.

Authors:  V K Lishko; I S Yermolenko; H Owaynat; T P Ugarova
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

2.  Deposition of fibrinogen on the surface of in vitro thrombi prevents platelet adhesion.

Authors:  Hadil Owaynat; Ivan S Yermolenko; Ramya Turaga; Valeryi K Lishko; Michael R Sheller; Tatiana P Ugarova
Journal:  Thromb Res       Date:  2015-10-09       Impact factor: 3.944

3.  Injury measurements improve interpretation of thrombus formation data in the cremaster arteriole laser-induced injury model of thrombosis.

Authors:  Steven P Grover; Pavan K Bendapudi; Moua Yang; Glenn Merrill-Skoloff; Vijay Govindarajan; Alexander Y Mitrophanov; Robert Flaumenhaft
Journal:  J Thromb Haemost       Date:  2020-10-29       Impact factor: 5.824

4.  Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice.

Authors:  Brian Cooley; William Funkhouser; Dougald Monroe; Ashley Ezzell; David M Mann; Feng-Chang Lin; Paul E Monahan; Darrel W Stafford
Journal:  Blood       Date:  2016-04-22       Impact factor: 22.113

Review 5.  Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology.

Authors:  Allan K Metz; Jose A Diaz; Andrea T Obi; Thomas W Wakefield; Daniel D Myers; Peter K Henke
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

6.  Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis.

Authors:  Christa L Pawlowski; Wei Li; Michael Sun; Kavya Ravichandran; DaShawn Hickman; Clarissa Kos; Gurbani Kaur; Anirban Sen Gupta
Journal:  Biomaterials       Date:  2017-03-14       Impact factor: 12.479

7.  The assembly of nonadhesive fibrinogen matrices depends on the αC regions of the fibrinogen molecule.

Authors:  Ivan S Yermolenko; Oleg V Gorkun; Alexander Fuhrmann; Nataly P Podolnikova; Valeryi K Lishko; Stanislav P Oshkadyerov; Susan T Lord; Robert Ros; Tatiana P Ugarova
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

8.  Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.

Authors:  J E Geddings; Y Hisada; Y Boulaftali; T M Getz; M Whelihan; R Fuentes; R Dee; B C Cooley; N S Key; A S Wolberg; W Bergmeier; N Mackman
Journal:  J Thromb Haemost       Date:  2015-12-11       Impact factor: 5.824

9.  Primary Human Lung Alveolus-on-a-chip Model of Intravascular Thrombosis for Assessment of Therapeutics.

Authors:  A Jain; R Barrile; A D van der Meer; A Mammoto; T Mammoto; K De Ceunynck; O Aisiku; M A Otieno; C S Louden; G A Hamilton; R Flaumenhaft; D E Ingber
Journal:  Clin Pharmacol Ther       Date:  2017-07-14       Impact factor: 6.875

10.  Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation.

Authors:  Stephanie A Smith; Sharon H Choi; Julie N R Collins; Richard J Travers; Brian C Cooley; James H Morrissey
Journal:  Blood       Date:  2012-09-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.